MedPath

Goal Directed Hemodynamic Management and Renal Outcome After Major Non-cardiac Surgery

Completed
Conditions
Major Non-cardiac Surgery
Interventions
Device: PiCCO® Monitoring
Registration Number
NCT01035541
Lead Sponsor
Technical University of Munich
Brief Summary

This study is designed to compare renal outcome of patients following major non-cardiac surgery with different perioperative hemodynamic managements: a goal directed hemodynamic management group (using PiCCO) and a control group.

Detailed Description

Acute kidney injury (AKI) is a common complication after major surgery. Many studies showed that AKI is associated with different complications: higher mortality, renal replacement therapy and prolonged hospital stay resulting in higher health care costs.

Until now just a few studies are published on prevention or therapy of AKI after major surgery. Most of these investigations are underpowered or show just marginal benefit. There are no studies published investigating the impact of goal-directed hemodynamic management on renal outcome following non-cardiac major surgery, even though hemodynamic stability seems to be of paramount importance for the kidneys.

Aim of this study is to investigate the impact of a goal directed hemodynamic management on renal outcome after major non-cardiac surgery.

Therefore patients will be randomized in one of two groups, the PiCCO group with goal directed hemodynamic management and the Control group, where PICCO data will be collected but will not influence hemodynamic management. In both groups the monitoring with transpulmonary thermodilution will be continued in the intensive care unit until 72 hours after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Elective major non-cardiac surgery lasting more than 3 hours with a following intensive care unit stay for more than 3 days:

    • gastrectomy
    • pancreas surgery
    • small bowel surgery
    • esophageal surgery
  • Age ≥ 18 years

  • ASA classification I to III

  • Written informed consent

Exclusion Criteria
  • Need for dialysis

  • Contraindications for an arterial line in the femoral artery:

    • stents
    • bypasses
    • severe peripheral artery occlusive disease
  • ASA classification IV to V

  • Pregnant Woman

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
C groupPiCCO® MonitoringConventional fluid management
P groupPiCCO® MonitoringFluid Management according to measurements with PiCCO®
Primary Outcome Measures
NameTimeMethod
maximum change in serum creatinine within 3 daysStart of anesthesia until third postoperative day (72 hours)
Secondary Outcome Measures
NameTimeMethod
incidence of AKI according to the RIFLE criteria, need for dialysis, pulmonal complications, rate of anastomotic insufficiency, sepsis, reoperation1 year

All points are additionnally registered one year after the operation via telephone-questionnaire of the patient and his general practitioner

Trial Locations

Locations (1)

Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München

🇩🇪

Munic, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath